Welcome to the Global Cardiovascular Innovation
Center
The Global Cardiovascular Innovation Center (GCIC)
announces the Summer 2008 round of the Commercialization Funding Program
beginning with a formal request for proposals to be released at the end of March, 2008.
The Global Cardiovascular Innovation Center is a $250 million product commercialization consortium made possible by a $60 million grant from the State of Ohio’s Third Frontier Project. The consortium is led by the Cleveland Clinic – the #1 ranked heart center in the US for the past 13 years – and is made up of other leading Ohio medical and research institutions including Case Western Reserve University, the Ohio State University, the University of Cincinnati, the University of Toledo and University Hospitals of Cleveland, along with leading industry and economic development partners.
Our Mission:
To be an international leader in developing, acquiring, incubating, and commercializing cardiovascular technology.
"Cleveland’s Global Cardiovascular Innovation Center is a 250 million dollar public-private partnership
formed to develop new cardiovascular products. It will create hundreds of new jobs, and more importantly,
it will help countless patients in Ohio and around the world overcome a terrible threat to their health.
The state’s commitment to bioscience is a major reason why Ohio hosts 25 percent of all clinical trials
conducted in the U.S. This is research that creates jobs and saves lives.”
- Ohio Governor Ted Strickland, State of the State Address, February 6, 2008
|
© 2007 Global Cardiovascular Innovation Center 